NPI: 1972517365 · LUBBOCK, TX 79410 · Ambulatory Surgical Clinic/Center · NPI assigned 07/28/2006
Authorized official ANDERSON, DONALD controls 20+ related entities in our dataset. Read more
| Authorized Official | ANDERSON, DONALD (ASSISTANT SECRETARY OF ENROLLMENTS) |
| NPI Enumeration Date | 07/28/2006 |
Other providers sharing the same authorized official: ANDERSON, DONALD
| Year | Claims | Total Paid |
|---|---|---|
| 2018 | 12,125 | $389K |
| 2019 | 8,893 | $204K |
| 2020 | 8,104 | $174K |
| 2021 | 50,256 | $988K |
| 2022 | 42,303 | $1.08M |
| 2023 | 32,330 | $940K |
| 2024 | 22,745 | $471K |
| Code | Description | Claims | Beneficiaries | Total Paid |
|---|---|---|---|---|
| 99285 | Emergency department visit for the evaluation and management, high severity with immediate threat to life | 4,746 | 4,424 | $859K |
| 99284 | Emergency department visit for the evaluation and management, high severity | 2,870 | 2,729 | $390K |
| 99283 | Emergency department visit for the evaluation and management, moderate severity | 5,250 | 5,030 | $372K |
| U0002 | 2019-ncov coronavirus, sars-cov-2/2019-ncov (covid-19), any technique, multiple types or subtypes (includes all targets), non-cdc | 2,775 | 2,701 | $182K |
| G0378 | Hospital observation service, per hour | 716 | 426 | $140K |
| 93005 | Electrocardiogram, routine ECG with at least 12 leads; tracing only, without interpretation and report | 4,804 | 4,176 | $131K |
| 95813 | 348 | 345 | $131K | |
| 93458 | 75 | 73 | $112K | |
| 80053 | Comprehensive metabolic panel | 14,119 | 11,727 | $110K |
| 85025 | Blood count; complete (CBC), automated, and automated differential WBC count | 17,721 | 14,193 | $99K |
| 87150 | 1,193 | 1,175 | $87K | |
| 43239 | Esophagogastroduodenoscopy, flexible, transoral; with biopsy, single or multiple | 182 | 177 | $87K |
| 87389 | Infectious agent antigen detection by immunoassay technique, HIV-1 antigen with HIV-1 and HIV-2 antibodies | 1,800 | 1,738 | $66K |
| 87491 | Infectious agent detection by nucleic acid; Chlamydia trachomatis, amplified probe | 1,313 | 1,256 | $61K |
| 87591 | Infectious agent detection by nucleic acid; Neisseria gonorrhoeae, amplified probe | 1,313 | 1,256 | $61K |
| 0202U | Oncology (prostate), multianalyte, gene expression profiling | 709 | 678 | $51K |
| 88313 | 372 | 326 | $49K | |
| 74177 | Computed tomography, abdomen and pelvis; with contrast material | 279 | 267 | $44K |
| 87086 | Culture, bacterial; quantitative colony count, urine | 4,677 | 4,383 | $41K |
| 83655 | 1,454 | 1,440 | $38K | |
| 70450 | Computed tomography, head or brain; without contrast material | 959 | 897 | $37K |
| 88342 | 287 | 257 | $37K | |
| 86780 | 1,787 | 1,720 | $35K | |
| 87804 | Infectious agent antigen detection by immunoassay; Influenza, each type | 1,408 | 1,062 | $34K |
| 80050 | General health panel | 743 | 724 | $34K |
| 80061 | Lipid panel | 2,234 | 2,149 | $34K |
| 96375 | Therapeutic injection; each additional sequential IV push | 1,899 | 1,481 | $31K |
| 87660 | 910 | 887 | $31K | |
| 71045 | Radiologic examination, chest; single view | 2,145 | 1,909 | $31K |
| 71046 | Radiologic examination, chest; 2 views | 1,023 | 996 | $29K |
| 88305 | Level IV - Surgical pathology, gross and microscopic examination | 611 | 586 | $29K |
| U0005 | Infectious agent detection by nucleic acid (dna or rna); severe acute respiratory syndrome coronavirus 2 (sars-cov-2) (coronavirus disease [covid-19]), amplified probe technique, cdc or non-cdc, making use of high throughput technologies, completed within 2 calendar days from date of specimen collection (list separately in addition to either hcpcs code u0003 or u0004) as described by cms-2020-01-r2 | 1,726 | 1,667 | $28K |
| 96376 | 1,361 | 675 | $28K | |
| 87480 | 968 | 944 | $27K | |
| 87635 | Infectious agent detection by nucleic acid; SARS-CoV-2 (COVID-19), amplified probe | 738 | 722 | $26K |
| 84702 | 1,210 | 1,013 | $26K | |
| 95957 | 262 | 257 | $25K | |
| 96374 | Therapeutic, prophylactic, or diagnostic injection; intravenous push, single or initial substance | 2,370 | 2,242 | $24K |
| 87510 | 972 | 944 | $23K | |
| 84443 | Thyroid stimulating hormone (TSH) | 2,316 | 2,219 | $21K |
| 87340 | 1,244 | 1,210 | $20K | |
| 96372 | Therapeutic, prophylactic, or diagnostic injection; subcutaneous or intramuscular | 2,417 | 1,290 | $19K |
| 80048 | Basic metabolic panel (calcium, ionized) | 3,282 | 2,506 | $19K |
| J3490 | Unclassified drugs | 1,196 | 779 | $19K |
| CP007 | 276 | 191 | $19K | |
| 99282 | Emergency department visit for the evaluation and management, low to moderate severity | 230 | 225 | $19K |
| G0463 | Hospital outpatient clinic visit for assessment and management of a patient | 589 | 579 | $18K |
| 0352U | 860 | 834 | $18K | |
| 86850 | 1,284 | 1,219 | $17K | |
| 82306 | Vitamin D; 25 hydroxy, includes fraction(s), if performed | 618 | 601 | $16K |
| 84703 | 2,124 | 2,024 | $15K | |
| 87880 | Infectious agent antigen detection by immunoassay; Streptococcus, group A | 1,011 | 994 | $15K |
| 0353U | 499 | 483 | $14K | |
| 84439 | 1,729 | 1,658 | $14K | |
| 84484 | 2,914 | 1,767 | $14K | |
| 83036 | Hemoglobin; glycosylated (A1C) | 1,989 | 1,936 | $14K |
| 86762 | 589 | 574 | $14K | |
| 86803 | 535 | 520 | $13K | |
| J0131 | Injection, acetaminophen, not otherwise specified,10 mg | 1,002 | 779 | $11K |
| 82784 | 750 | 317 | $8K | |
| 85730 | 1,932 | 1,819 | $8K | |
| 82785 | 237 | 235 | $8K | |
| 85610 | 2,775 | 2,486 | $8K | |
| 82962 | 6,744 | 1,829 | $8K | |
| C1769 | Guide wire | 215 | 203 | $7K |
| 93306 | Echocardiography, transthoracic, real-time with image documentation, with and without Doppler, complete | 44 | 42 | $6K |
| 85027 | 1,334 | 1,128 | $6K | |
| 83690 | 1,354 | 1,246 | $6K | |
| J3010 | Injection, fentanyl citrate, 0.1 mg | 2,209 | 1,940 | $6K |
| J2405 | Injection, ondansetron hydrochloride, per 1 mg | 2,833 | 2,201 | $6K |
| J2704 | Injection, propofol, 10 mg | 1,479 | 1,334 | $6K |
| 36415 | Collection of venous blood by venipuncture | 4,484 | 3,790 | $6K |
| 82950 | 760 | 741 | $6K | |
| 83880 | 1,000 | 884 | $6K | |
| 87636 | Infectious agent detection by nucleic acid; SARS-CoV-2 and influenza virus types A and B | 106 | 100 | $5K |
| 74176 | Computed tomography, abdomen and pelvis; without contrast material | 96 | 94 | $5K |
| 86900 | 1,190 | 1,148 | $5K | |
| 81001 | 2,697 | 2,478 | $5K | |
| 96361 | Intravenous infusion, hydration; each additional hour | 257 | 245 | $5K |
| J1644 | Injection, heparin sodium, per 1000 units | 976 | 537 | $5K |
| 86901 | 1,180 | 1,139 | $5K | |
| 80047 | 398 | 354 | $4K | |
| 83735 | 1,252 | 802 | $4K | |
| U0003 | Infectious agent detection by nucleic acid (dna or rna); severe acute respiratory syndrome coronavirus 2 (sars-cov-2) (coronavirus disease [covid-19]), amplified probe technique, making use of high throughput technologies as described by cms-2020-01-r | 449 | 424 | $4K |
| J2250 | Injection, midazolam hydrochloride, per 1 mg | 1,315 | 1,170 | $4K |
| 80307 | Drug test(s), presumptive, any number of drug classes; immunoassay | 353 | 315 | $4K |
| 99152 | 236 | 224 | $3K | |
| Q9967 | Low osmolar contrast material, 300-399 mg/ml iodine concentration, per ml | 1,889 | 1,794 | $3K |
| J2270 | Injection, morphine sulfate, up to 10 mg | 839 | 597 | $3K |
| C1894 | Introducer/sheath, other than guiding, other than intracardiac electrophysiological, non-laser | 158 | 155 | $3K |
| 81025 | 384 | 378 | $3K | |
| 99281 | Emergency department visit for the evaluation and management, self-limited or minor | 41 | 40 | $3K |
| 87077 | 1,131 | 1,048 | $3K | |
| 87797 | 63 | 59 | $3K | |
| 96365 | Intravenous infusion, for therapy, prophylaxis, or diagnosis; initial, up to 1 hour | 159 | 149 | $3K |
| 87186 | 1,005 | 911 | $2K | |
| J1885 | Injection, ketorolac tromethamine, per 15 mg | 876 | 753 | $2K |
| 93976 | 25 | 24 | $2K | |
| 81003 | 1,490 | 1,422 | $2K | |
| 82150 | 322 | 302 | $2K | |
| A9270 | Non-covered item or service | 3,426 | 1,055 | $2K |
| 0240U | 203 | 197 | $2K | |
| 87070 | 176 | 167 | $2K | |
| 71275 | Computed tomographic angiography, chest, with contrast material | 13 | 12 | $2K |
| 97110 | Therapeutic procedure, each 15 minutes; therapeutic exercises to develop strength and endurance, flexibility and range of motion | 34 | 12 | $2K |
| 87801 | Infectious agent detection by nucleic acid; amplified probe, multiple organisms | 17 | 17 | $2K |
| C1887 | Catheter, guiding (may include infusion/perfusion capability) | 109 | 103 | $2K |
| J1100 | Injection, dexamethasone sodium phosphate, 1 mg | 730 | 676 | $2K |
| 94010 | 37 | 37 | $2K | |
| J1650 | Injection, enoxaparin sodium, 10 mg | 552 | 236 | $2K |
| J0690 | Injection, cefazolin sodium, 500 mg | 518 | 354 | $1K |
| 81000 | 416 | 384 | $1K | |
| 83789 | 37 | 36 | $1K | |
| 76937 | 68 | 63 | $1K | |
| S3620 | Newborn metabolic screening panel, includes test kit, postage and the laboratory tests specified by the state for inclusion in this panel (e.g., galactose; hemoglobin, electrophoresis; hydroxyprogesterone, 17-d; phenylalanine (pku); and thyroxine, total) | 103 | 92 | $1K |
| 83525 | 47 | 47 | $1K | |
| J2001 | Injection, lidocaine hcl for intravenous infusion, 10 mg | 527 | 475 | $1K |
| 83605 | 373 | 317 | $1K | |
| 86800 | 52 | 50 | $1K | |
| 83516 | 67 | 64 | $1K | |
| J0134 | Injection, acetaminophen (fresenius kabi), not therapeutically equivalent to j0131, 10 mg | 293 | 274 | $963.97 |
| 86376 | 50 | 48 | $929.72 | |
| 87634 | 12 | 12 | $875.12 | |
| 85018 | 208 | 202 | $792.12 | |
| 85014 | 255 | 231 | $787.45 | |
| J1170 | Injection, hydromorphone, up to 4 mg | 217 | 152 | $775.20 |
| 87081 | 54 | 54 | $769.24 | |
| 82607 | 108 | 107 | $760.77 | |
| 82746 | 82 | 82 | $713.51 | |
| J0696 | Injection, ceftriaxone sodium, per 250 mg | 286 | 203 | $688.21 |
| 87040 | 164 | 91 | $599.21 | |
| 72125 | Computed tomography, cervical spine; without contrast material | 74 | 69 | $594.10 |
| 83615 | 58 | 55 | $557.62 | |
| 84132 | 246 | 175 | $478.52 | |
| 82951 | 17 | 17 | $463.20 | |
| 80076 | 47 | 43 | $445.41 | |
| 86140 | 137 | 100 | $426.46 | |
| 84550 | 58 | 55 | $417.92 | |
| 97161 | 27 | 24 | $390.07 | |
| 84305 | 12 | 12 | $333.86 | |
| 82728 | 12 | 12 | $320.69 | |
| 99153 | Mod sedat endo service >5yrs | 12 | 12 | $205.43 |
| 82575 | 12 | 12 | $152.00 | |
| 82952 | 17 | 17 | $140.95 | |
| 85007 | 47 | 40 | $125.53 | |
| 84156 | 16 | 14 | $80.85 | |
| 87502 | Infectious agent detection by nucleic acid, influenza virus, for multiple types or subtypes, includes all targets | 64 | 52 | $80.47 |
| 83721 | 18 | 18 | $79.37 | |
| J1815 | Injection, insulin, per 5 units | 107 | 36 | $64.36 |
| 80179 | 13 | 12 | $49.22 | |
| 80143 | 13 | 12 | $49.22 | |
| 80164 | 87 | 80 | $48.93 | |
| 82077 | 15 | 13 | $46.92 | |
| Q9966 | Low osmolar contrast material, 200-299 mg/ml iodine concentration, per ml | 36 | 34 | $44.22 |
| 85652 | 14 | 12 | $39.34 | |
| 80069 | 38 | 27 | $29.08 | |
| 87088 | 29 | 28 | $26.06 | |
| 80177 | 18 | 17 | $20.59 | |
| 87205 | 16 | 12 | $16.44 | |
| J0330 | Injection, succinylcholine chloride, up to 20 mg | 12 | 12 | $14.16 |
| A4216 | Sterile water, saline and/or dextrose, diluent/flush, 10 ml | 14 | 13 | $11.92 |
| 82570 | 14 | 14 | $10.81 | |
| G1004 | Clinical decision support mechanism national decision support company, as defined by the medicare appropriate use criteria program | 2,126 | 1,480 | $0.00 |
| 82805 | 13 | 13 | $0.00 | |
| 84100 | 13 | 12 | $0.00 |